Watch Ticker

Cellectar Biosciences INC NEW

Go to Cellectar Biosciences INC NEW Website

$5.04

0.32 (6.78%)

Live

Previous Close

$4.72

Day Range

$4.77 - $5.09

Previous Day Range

$4.4406 - $4.921

Market Cap

$13.5 million USD

Day Vol.

145885

Previous Day Vol.

84592

Currency

USD

Primary Exchange

Nasdaq

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid d...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Waldenstrom Macroglobulinemia Market Sees Surging Demand Across the 7MM Amid BTK Inhibitor Advancements | DelveInsight

The Waldenstrom macroglobulinemia market is experiencing steady growth driven by advances in targeted therapies, particularly BTK inhibitors. Rising awareness, improved diagnostics, and increasing clinical trials are propelling market expansion, with several emerging drugs showing promise in treating this rare lymphoma.

Related tickers: CLRB, BGNE, ONC, MRK, NRIX.

Read Full Article

N/A - Cellectar Biosciences Announces Compliance Regarding Filing of Form 10-Q

Cellectar Biosciences, Inc. announced that it has regained compliance with Nasdaq Listing Rule 5250(c)(1) after filing restated financial statements for 2022, 2023, and the first half of 2024.

Related tickers: CLRB.

Read Full Article

Trending Tickers

Please sign in to view